Loading...
•
Dec 31, 2020
Co-Diagnostics Q4 2020 Earnings Report
Reported record quarterly results with revenue of $27.1 million and pre-tax income of $15.8 million.
Key Takeaways
Co-Diagnostics reported record fourth-quarter results, driven by demand for its Logix Smart COVID-19 Test. Revenue reached $27.1 million, and pre-tax income was $15.8 million.
Co-Diagnostics reported record quarterly revenue of $27.1 million.
Pre-tax income for the quarter was $15.8 million.
Demand for Logix Smart COVID-19 Test drove record sales.
The company anticipates continued demand for its COVID-19 tests and other diagnostic products in 2021.
Forward Guidance
Co-Diagnostics anticipates continued demand for its COVID-19 tests and other diagnostic products as testing becomes a part of the long-term protocol for many organizations. The company expects its distribution platform, production capacity, product reliability, and ongoing product innovation will position it for additional growth throughout the world.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...